Medigus Ltd. (NASDAQ:MDGS) Short Interest Down 17.6% in March

Medigus Ltd. (NASDAQ:MDGS) saw a large decline in short interest during the month of March. As of March 31st, there was short interest totalling 4,200 shares, a decline of 17.6% from the March 15th total of 5,100 shares. Based on an average trading volume of 8,500 shares, the short-interest ratio is presently 0.5 days. Approximately 0.3% of the company’s shares are sold short.

Hedge Funds Weigh In On Medigus

A hedge fund recently bought a new stake in Medigus stock. Virtu Financial LLC purchased a new stake in Medigus Ltd. (NASDAQ:MDGS) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 61,809 shares of the company’s stock, valued at approximately $40,000. Virtu Financial LLC owned 0.39% of Medigus as of its most recent SEC filing. Institutional investors and hedge funds own 0.26% of the company’s stock.

Medigus Trading Up 4.2 %

Shares of Medigus stock opened at $2.50 on Monday. The firm has a fifty day moving average of $2.79 and a two-hundred day moving average of $3.12. Medigus has a 52 week low of $2.35 and a 52 week high of $7.17.

About Medigus

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments.